Improved bioavailability of a micronized megestrol acetate tablet formulation in humans

Drug Development and Industrial Pharmacy

Volumn 26, Issue 5, 2000, Pages 567-570

  Farinha, A ^a   Bica, A ^a   Tavares, P ^a  

^a Laboratorio de Estudos Farmaceuticos   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MEGESTROL ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TABLET;

EID: 0034003917     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101270     Document Type: Article

References (9)

1. Martindale, The Extra Pharmacopoeia, 30th ed. (J. E. F. Reynolds, Ed.), Pharmaceutical Press, London, 1993.
2. R. C. Gaver, Sem. Oncol., 12(suppl. 1), 1, 17-19 (1985).
3. C. M. Camaggi, Cancer Chemother. Pharmacol., 36, 356-359 (1995).
4. R. C. Gaver, Biopharm. Drug Dispos., 7, 35-46 (1986).
5. U.S. Pharmacopeial Convention, The United States Pharmacopeia 23/National Formulary 18, Author, Rockville, MD, 1995.
6. U.S. Food and Drug Administration, Guidance: statistical procedures for bioequivalence studies using a standard two-treatment crossover design, informal communication under 21 CFR 10.90(b)(a) (1992).
7. D. J. Schuirmann, J. Pharmacokinet. Biopharm., 15, 657-680 (1987).
8. D. Hauschke, V. W. Steinijans, and E. Diletti, Int. J. Clin. Pharmacol. Ther. Toxicol., 28, 105-110 (1992).
9. V. W. Steinijans, R. Sauter, D. Hauschke, E. Diletti, R. Schall, H. G. Luus, M. Elze, H. Blume, C. Hoffmann, G. Franke, and W. Siegmund, Int. J. Clin. Pharmacol. Ther., 33, 427-430 (1995).